Table 1.

Statin use and prevalence of indications for statin use among REGARDS Study participants with CKD

Participants SubgroupseGFR<60 ml/min per 1.73 m2 or ACR≥30 mg/geGFR<60 ml/min per 1.73 m2ACR≥30 mg/g
Total participants, n472622503276
Taking statins, n (%)2366 (50.0)1262 (56.1)1566 (47.8)
History of ASCVD, n (%)1676 (35.5)902 (40.1)1145 (35.0)
Diabetes, n (%)1857 (39.3)825 (36.7)1440 (44.0)
LDL-C≥190 mg/dl, n (%)153 (3.2)75 (3.3)112 (3.4)